Sample
Biological products
Intended Use
It is applicable to the optimization of purification process of biological products, impurity control of intermediate process and release testing of final products.
Contents of Kit
| No. | Components | Size | Storage Conditions |
| 1 | Standard | lyophilized powder × 2 pieces | 2-8°C |
| 2 | Coated Plate | 8 wells × 12 strips | 2-8°C |
| 3 | Sample Diluent | 15 mL × 1 vial | 2-8°C |
| 4 | Assay Buffer | 12 mL × 1 vial | 2-8°C |
| 5 | Wash Buffer (10×) | 50 mL × 1vial | 2-8°C |
| 6 | Detection Antibody | 6 mL × 1 vial | 2-8°C |
| 7 | Streptavidin-HRP | 12 mL × 1 vial | 2-8°C |
| 8 | TMB Substrate | 15 mL × 1 vial | 2-8°C |
| 9 | Stop Solution | 10 mL × 1 vial | 2-8°C |
| 10 | Sealing Film | 5 pieces | 2-8°C |
| 11 | Instructions for Use | 1 copy | |
Storage
Sealed kits are valid for 12 months at 2-8°C.
Detection Range
6.86-5000 pg/mL
Citations
Have you cited DEIA-PX0005 in a publication?
Let us know and earn a reward for your research.
| Product Name |
Cat. No. |
Applications |
Host Species |
Datasheet |
Price |
Add to Basket |
| Product Name |
Cat. No. |
Applications |
Host Species |
Datasheet |
Price |
Add to Basket |
van Dommelen, SLH; Sumaria, N; et al. Perforin and granzymes have distinct roles in defensive immunity and immunopathology. IMMUNITY 25:835-848(2006).
Kobayashi, M; Kaneko-Koike, C; et al. Genetic deletion of granzyme B does not confer resistance to the development of spontaneous diabetes in non-obese diabetic mice. CLINICAL AND EXPERIMENTAL IMMUNOLOGY 173:411-418(2013).
COA
Certificate of Analysis
